STERIS PLC
STENYSE🏆 #495 by market capEarnings Nov 5US Equity
$228.70▲ $0.27 (+0.12%)
Market closed · at closeTrack STE
Get earnings, price moves & breaking news on Telegram
24h▲ 0.1%
7d▼ 1.5%
14d▲ 1.9%
30d▲ 8.7%
ytd▼ 9.9%
1y▼ 3.4%
🏦Market Cap
$22.30B
Mid Cap
📈Revenue Growth (YoY)
8.4%
Slowing
📊Gross Margin
44.4%
Healthy
💵FCF Margin
15.3%
Healthy
⚖️P/S Ratio
3.7x
Fair
Otter Score
76
Strong
Trading Snapshot
- Day Range
- $226.90 – $229.96
- 52-Week Range
- $195.14 – $269.44
- Volume (shares)
- 34,262
- Avg Volume (shares)
- —
- Shares Outstanding
- 97.5M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $5.94B
- Last Q Revenue
- $1.49B
- P/E Ratio
- 27.8
- P/S Ratio
- 3.7x
- EPS (TTM)
- $8.19
- Dividend Yield
- 1.10%
- Dilution (1yr)
- −0.9%
STERIS PLC
STEFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$5.9B▲ +8.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
44.2%▲ +0.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$1.1B▲ +27.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$972M▲ +25.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
97.9M▼ −0.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$1.6B▲ +$68M YoY
StockOtter · stockotter.spaceAbout STERIS PLC
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Strong
76/100
Analyst Ratings
ⓘConsensus
Buy
14 analysts
Strong Buy3
Buy7
Hold4
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.